Osteosarcoma is an aggressive bone tumor primarily affecting children and adolescents. Its cause is not yet fully understood, and there is an urgent need for more effective treatment. In the present study we identified several miRNAs whose expression is altered in osteosarcoma compared to adjacent normal tissue. Moreover, expression levels of one of those miRNAs, miR-506-3p, correlated negatively with expression of RAB3D (a Rasrelated protein). Suppression of miR-506-3p in osteosarcoma led to increased expression of RAB3D, which in turn led to increased CDK4 (cyclin-dependent kinase 4) and MMP9 (matrix metalloprotein 9) activities. Our results suggest that miR-506-3p acts as a tumor suppressor in osteosarcoma and that its downregulation leads to tumor cell proliferation and metastasis due to upregulation of RAB3D-and CDK4-mediated signaling. miR-506-3p thus appears be a potentially useful target for adjuvant therapy in osteosarcoma patients.
INTRODUCTION
Osteosarcoma is a highly malignant cancer occurring primarily in adolescents. About 75% of the patients are 15-25 years old, and most are male. The prognosis of osteosarcoma patients is very poor [1] , and new and more effective methods of treatment of this disease are greatly needed.
Studies have shown that alterations in miRNA expression are associated with a variety of human diseases, including cancer and nervous and digestive system diseases [2] . In the context of cancer, miR-506 overexpression in HCT116-OxR cells enhances oxaliplatin sensitivity by inhibiting MDR1/P-gp expression via down-regulation of the Wnt/β-catenin pathway and thus provides a rationale for the development of miRNA-based strategies to reverse oxaliplatin resistance in colorectal cancer cells [3] . MiR-506 also suppresses neuroblastoma metastasis by targeting ROCK1 [4] , and downregulation of miR-506 expression facilitates pancreatic cancer progression [5] . In osteosarcoma, downregulated miR-506 expression promotes osteosarcoma cell growth through JAG1 [6] . Overexpression of miR-506 suppresses proliferation and promotes apoptosis of osteosarcoma cells by targeting astrocyte elevated gene-1 [7] and suppresses Snail2-mediated osteosarcoma invasiveness [8] .
RAB GTPases control exocytic and endocytic membrane trafficking such as exosome release. RAB3D is an essential regulator for protein secretion. In addition, within cancer cells RAB3D activates intracellular AKT/GSK3β signaling to induce growth and metastasis [9] . The role of RAB3D in osteosarcoma progression has never been systematically studied. In the present study, therefore, we examined the relation between miR-506-3p and RAB3D in osteosarcoma tissues and several osteosarcoma cell lines. Our findings suggest miR-506-3p functions as a tumor suppressing by targeting RAB3D expression in osteosarcoma cells. These results provide a theoretical AGING foundation of molecular targeted therapy in osteosarcoma.
RESULTS

Identification of differentially expressed miRNAs in osteosarcoma
The miRNA microarray showed 10 miRNAs to be downregulated (P<0.05) and 8 to be overexpressed (P<0.05) in osteosarcoma tissues compared with adjacent normal tissues ( Table 1 ). The expression of miRNAs exhibiting >30-fold change between osteosarcoma tissues and adjacent normal tissues was assessed using real time PCR ( Figure 1A ). Among these, miR-506-3p was decreased significantly in osteosarcoma tissues (Table 2) . Moreover, survival analysis showed that patients with higher miR-506-3p expressionsurvived for longer periods ( Figure 1B ). Consistent with these findings, miR-506-3p expression was also downregulated in osteosarcoma cell lines ( Figure 1C ).
RAB3D is a direct target of miR-627-3p
We found that miR-506-3p could be combined with 3'-UTR of RAB3D using miRDB (Figure 2A ). Real time PCR showed that RAB3D expression was significantly higher in osteosarcoma tissues than in adjacent normal tissues ( Figure 2B ). Survival analysis showed that the patients with lower RAB3D expression survived for longer periods ( Figure 1C ). We also observed that RAB3D is upregulated in osteosarcoma cell lines ( Figure 2D ) and that there is a negative correlation between the expression levels miR-506-3p and RAB3D in osteosarcoma ( Figure 2E ). Luciferase reporter assays showed that miR-506-3p reduces expression of RAB3D at the transcriptional level in hFOB 1.19, HEK 293, and cos7 cells ( Figure 2F ). When cells were co-transfected with RAB3D and miR-506-3p, luciferase activity was suppressed. However, no suppression was seen when cells were co-transfected with RAB3Dmut or miR-506-3p antisense. In addition, when we transfected miR-506-3p mimics or miR-506-3p inhibitors into osteosarcoma cells, western blotting and real-time PCR show- 
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ed that RAB3D expression suppressed by miR-506-3p mimics but enhanced by miR-506-3p inhibitors ( Figure  2G -J).
MiR-506-3p inhibits osteosarcoma cell proliferation
MTT assays showed that transfection of miR-506-3p mimics inhibited HOS and MG63 cell proliferation ( Figure 3A, B) . Previous studies showed that RAB3D stimulates cell cycle progression through effects on CDK4 signaling [11] . Consistent with that finding, we observed that miR-506-3p suppressed CDK4 expression in HOS cells ( Figure 3C-F) .
MiR-506-3p inhibits osteosarcoma metastasis
Transwell assays showed that transfecting HOS and MG63 cells with miR-506-3p mimics suppressed their Matrigel invasion as compared to transfection with scrambled controls (Figure 4A-D) . Conversely, the miR-506-3p inhibitor significantly increased the invasiveness of HOS and MG63 cells. Western blot and real-time PCR showed that MMP9 was significantly downregulated by miR-506-3p ( Figure 4E -H).
Effects of miR-627-3p siRNA and PTN siRNA on the proliferation and metastasis of HOS cells
After co-expressing miR-506-3p inhibitors/control and si-RAB3D/control in HOS cells, MTT and transwell experiments showed that silencing RAB3D suppressed HOS cell proliferation and invasiveness ( Figure 5A , B). When RAB3D and miR-506-3p were inhibited simultaneously, cells proliferation and invasiveness was somewhat higher. Western blotting and real time PCR showed that miR-506-3p expression had similar suppressive effects on RAB3D, CDK4 and MMP2 in HOS cells ( Figure 5C , D). 
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MiR-627-3p inhibits HOS cell invasion in vivo
To examine the effect of miR-506-3p on osteosarcoma cell invasiveness in vivo, HOS cells stably expressing vector (control) or miR-627 agomir were injected into nude mice via the tail vein. Histological analysis of liver tissues were collected 21 days later showed lower levels of hepatic invasion by HOS cells in mice injected with miR-506-3p agomir cells ( Figure 6A ). This finding was confirmed by hematoxylin and eosin staining which showed that as compared to control, miR-506-3p suppressed metastatic spread of HOS cells to the livers ( Figure 6B, C) . 
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DISCUSSION
The development and progression of osteosarcoma appears to be affected by a variety of factors, including miRNAs, which are known suppress/stimulate cell proliferation and/or metastasis of several cancers. In the present study, our microarray analysis showed that miR-506-3p expression is frequently suppressed in human osteosarcoma and that there is a negative correlation between miR-506-3p expression and survival among osteosarcoma patients. miR-506-3p reportedly suppresses the development and progression of tumors by targeting such proteins as LAMC1 and COLT1 [12, 13] . Previously studies observed that RAB3D plays a key role in osteosarcoma [14, 15] . To extend that observation, we assessed the relation between miR-506 and RAB3D, a member of the Rab GTPase family, which regulate membrane trafficking. Using miR-506-3p gain-and loss-offunction approaches as well as a tumor model in nude mice, we revealed that miR-506-3p suppresses the proliferation and invasiveness of osteosarcoma cells by targeting RAB3D transcription. Silencing of RAB3D suppresses the proliferation and invasiveness of esophageal squamous cell carcinoma cells [16] . Conversely, high RAB3D expression is associated with tumor progression and is predictive of a poor prognosis in colorectal cancer [11] . Moreover, RAB3D levels are much higher in breast, prostate, lung, colon, ovary, liver and skin carcinoma tissues than in corresponding normal tissues [17] [18] [19] . This suggests RAB3D could potentially serve as a broad-spectrum diagnostic biomarker for tumor progression relevant to both patient diagnosis and treatment [9] . Studies have showed that RAB3D influences cell proliferation by stimulating cell cycle progression through effects on CDK4 and CDK6 signaling [20, 21] . In addition, RAB3D appears to promote invasion by enhancing MMP expression [22, 23] .
In summary, our results suggest that miR-506-3p acts as a tumor suppressor in osteosarcoma and that its downregulation leads to tumor cell proliferation and metastasis due to upregulation of RAB3D-and CDKmediated signaling. miR-506-3p thus appears be a potentially useful target for adjuvant therapy in osteosarcoma patients.
MATERIALS AND METHODS
Tissue samples and cell lines
Primary osteosarcoma tumor samples and adjacent normal tissues were obtained from 30 patients in the Shengjing Hospital. The average age of the patients was 21.21 years (range: 11 to 41 years), and 21 of the patients were male. More than 90% of osteosarcomas occurred in extremities. All tumor samples were high-grade osteosarcomas at stage IIA or IIB in the Enneking system, except four tumors were stage III. The osteosarcoma subtypes included conventional (43.33%, 13/30), osteoblastoma-like (26.67%, 8/30), chondroblastoma-like (23.33%, 7/30), fibroblastic (3.33%, 1/30), and fibrohistiocytic (3.33%, 1/30). This study was approved by the 
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Research Ethics Committee of Shengjing Hospital, and all patients provided written informed consent. hFOB 1.19, 293, cos7, HOS, U2OS and MG63 cells were purchased from the cell bank of the Chinese Academy of Sciences. Cells were incubated at 37°C under a 5% CO 2 atmosphere and passaged every 2-3 days.
RNA isolation
Total RNAs including miRNAs were isolated from frozen tissues using Trizol according to the manufacture's protocol. Samples were then stored at -80°C until use.
MicroRNA microarray analysis
miRNA microarray analysis was outsourced to RiBio Cor (Ribobio, China). Briefly, total RNA extract was purified from the tissues using a mirVana™ miRNA Isolation Kit (TIANGEN, China) and then labeled and hybridized using an Agilent miRNA Complete Labeling and Hybridization Kit (Agilent Technologies, USA). The labeled RNA was examined using an Axon GenePix 4000B microarray scanner. miRNAs whose expression levels changed at least 2-fold between the tumor specimens collected before and after chemotherapy for used for further analysis [24] .
Real-time PCR
To detect expression of miRNAs and mRNAs, real time PCR was performed using a Reverse Transcription Kit Ribobio (Ribobio, China) according to the manufacturer's instructions. After treating samples with DNase I, cDNA was reverse transcribed from the total RNA using a miRNA-specific primer with a TaqMan® micro- Table 3 . Primer sequences.
Name
Forward primer ( All the reactions were carried out as described previously [27] .
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RNA reverse transcription kit (Ribobio, China). The real-time PCR reaction mixture (10 μl) contained 0.5 μl of RT product, 5 μl of TaqMan 2× Universal PCR Master Mix (Ribobio, China), and 1 μl of TaqMan miRNA Assay reagent (Ribobio, China). Real-time PCR protocol entail incubation at 95°C for 10 min, followed by 50 cycles at 95°C for 15 s and 60°C for 1 min. U6 and β-actin were used as internal controls. Expression of miRNAs was detected using a Stem-Loop RT-PCR assay as described previously [25, 26] . Primer sequences are listed in Table 3 .
Western blot analysis
Treated cells were collected by centrifugation at 300× g for 10 min and then lysed using radio immunoprecipitation assay buffer (Beyotime, China) containing 2 mM phenylmethanesulfonyl fluoride. Proteins in samples of lysate were resolved by 10% SDS-PAGE and transferred onto PVDF membranes. After incubition in blocking solution (4% bovine serum albumin in Tris-buffered saline and Tween-20) for 2 h at room temperature, the membranes were incubated with primary antibodies overnight at 4°C. Thereafter, the membranes were incubated with secondary antibodies for 2 h at room temperature. The primary antibodies used were anti-RAB3D (1:500), anti-CDK4 (1:500), anti-MMP9 (1:500), and anti-β-actin (1:2000) . HRPconjugated anti-mouse (1:5000) and anti-rabbit (1:5000) served as secondary antibodies (Santa Cruz, USA). Expression levels of proteins were quantified and normalized to levels of β-actin.
Dual luciferase reporter assay
Dual luciferase activity assays were performed as described previously [27] . The RAB3D 3'-UTR was PCR amplified and cloned into the pMIR-REPORTTM vector (Ambion, China). The primers used were as follows: for RAB3D-wt, 5'-TGGTGGGGAACAAGT GTGAC -3' (forward) and 5'-GGAATGAGCCATGC AGGAGT -3' (reverse); for RAB3D-mut (the miR-506-3p binding site was mutated), 5'-CCCCAAGATCCAC ATCACCC -3' (forward) and 5'-CCCTGCCGATGAC AAGGATT -3' (reverse). Twenty-four hours before transfection, 1×10 4 MG63 cells were plated in a 96-well plate. miR-506-3p mimics, inhibitors or control was transfected into cells together with 100 ng of RAB3D-wt or RAB3D-mut. Luciferase activity was assessed using a Dual Luciferase Reporter Assay System (Promega, USA) 24 h after transfection.
MTT assays
After transfecting HOS or MG63 cells with miR-506-3p mimics or inhibitors, the cells were seeded onto 96-well plates to a density of 2×10 3 cells per well and incubated in the corresponding medium supplemented with 10% FBS. After incubation for 0, 12, 24 or 48 h, 10 µl of MMT was adding into each well, and the cells were incubated for an additional 4 h. Absorbance at 490 nm was then measured. Experiments were carried out in triplicate.
Transwell assay
HOS and MG63 cells were transfected with miRNA mimics, inhibitors or control. Twenty-four hours after transfection, 1×10
5 cells in serum-free medium were seeded into transwell chambers with or without a Matrigel-covered membrane. After 8 h, the cells were fixed with 4% paraformaldehyde, stained with 0.4% trypan blue, and counted using a microscope.
Nude mice experiment
Five-to six-week-old female, athymic nude BALB/c mice (Vital River Laboratory Animal Technology Co. Ltd., China) were used to study tumor metastasis. Mice administered 2×10 6 cells suspended in 1 ml saline via the tail vein were divided into miR-506-3p agomir and control groups (n=6 in each group). On day 21 after tumor cell injection, liver samples were collected for histological examination.
All experimental procedures involving animals were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (NIH publication no. 80-23, revised 1996) and were performed according to the institutional ethical guidelines for animal experiments.
Histopathology
Liver specimens were fixed with 4% paraformaldehyde. Serial sections (2 μm) were cut using a microtome and affixed onto positively charged slides. All slides were incubated at 60°C for several hours to allow the sections to adhere to the slides. Tissues sections were deparaffinized and rehydrated through a graded xylene and alcohol series. Hematoxylin-eosin staining was performed using standard protocols.
Statistical analysis
All statistical analyses were performed using SPSS software, version 17.0 (SPSS Inc., Chicago, IL, USA). Data are presented as the mean ± standard deviation. Two groups were compared using Student's t test (twotailed) and one-way ANOVA. Multiple comparisons were made using one-way ANOVA and the LSD-t method. Statistical significance was defined as P<0.05. All experiments were repeated three times.
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